Life Sciences Archives - REBusinessOnline

GSK to Invest $800M in Metro Philadelphia Life Sciences, Manufacturing Facilities, Create 300 New Jobs

Taylor Williams — Mon, 19 Oct 2026 11:51:00 +0000

UPPER MERION, PA. — Global pharmaceutical company GSK plc (NYSE: GSK) will invest $800 million in its life sciences and manufacturing facilities in metro Philadelphia, an initiative that is expected to create about 300 new jobs within the local economy. The announcement is a follow-up to the company’s pledge in late September to invest $30 billion in research-and-development (R&D) and manufacturing initiatives over the next five years, with $1.2 billion earmarked for expanding its existing technologies and advanced manufacturing sites, including its metro Philadelphia facilities. The existing facilities are located in Upper Merion Township, about 20 miles northwest of Philadelphia. The expansion will involve some demolition of existing facilities to establish a biopharmaceutical innovation and manufacturing hub, integrating commercial production, R&D and advanced digital capabilities in a single site. Construction is scheduled to begin next year. The new jobs are expected to be created over a five-year period, bringing GSK’s total employment in the region to about 4,500 positions. GSK announced a similar $800 million investment in its pharmaceutical and biotechnology facilities in Lancaster, about 70 miles west of Philadelphia, about two years ago. The company will be eligible for tax benefits through Pennsylvania’s Qualified Manufacturing Innovation and Reinvestment Deduction…

The post GSK to Invest $800M in Metro Philadelphia Life Sciences, Manufacturing Facilities, Create 300 New Jobs appeared first on REBusinessOnline.

Cushman & Wakefield Brokers $4.7M Sale of Industrial, Life Sciences Building in East Windsor, New Jersey

Taylor Williams — Wed, 14 Oct 2026 12:17:49 +0000

EAST WINDSOR, N.J. — Cushman & Wakefield has brokered the $4.7 million sale of a 27,992-square-foot industrial and life sciences building in East Windsor, located outside of Trenton in Central New Jersey. The building at 55 Lake Drive was constructed in 1974 (renovated in 2013) and was vacant at the time of sale. Dan Bottiglieri, Deb Boucher, Jordan Sobel, Andrew Schwartz, Andre Balthazard, Mike Dean and Kate Boyle of Cushman & Wakefield represented the seller, Danish biotechnology company Novonesis, in the transaction. The team also procured the undisclosed buyer.

The post Cushman & Wakefield Brokers $4.7M Sale of Industrial, Life Sciences Building in East Windsor, New Jersey appeared first on REBusinessOnline.

JLL Arranges $237.7M Loan for Life Sciences Campus in Research Triangle Park

John Nelson — Tue, 13 Oct 2026 15:42:15 +0000

MORRISVILLE, N.C. — JLL has arranged $237.7 million loan for Phase I of Pathway Triangle, a life sciences campus underway in North Carolina’s Research Triangle Park (RTP). Phase I comprises four life sciences and advanced manufacturing buildings totaling 581,789 square feet on McCrimmon Parkway in Morrisville, about 14 miles west of Raleigh. Brett Paulsrud, Amy Lousararian, Andrew Gray, Ward Smith, Hugh Doherty and Libby Horton of JLL arranged the loan through Starwood Property Trust on behalf of the borrower, King Street Properties. Two buildings totaling 377,111 square feet have been completed at Pathway Triangle and are 73 percent leased. Building 1 is partially leased to Liquidia Pharmaceuticals for the manufacturing of Yutrepia, an FDA-approved inhalation powder treating pulmonary arterial hypertension. Building 2 is fully leased to Novartis. Construction began recently on the other two Phase I buildings — Building 4 (148,434 square feet) and Building 7 (56,244 square feet), which is fully preleased to Novartis. A second phase is planned for Pathway Triangle, upon completion of which the campus will span 950,000 square feet.

The post JLL Arranges $237.7M Loan for Life Sciences Campus in Research Triangle Park appeared first on REBusinessOnline.

Duracell Opens Regional Office at Science Square Labs in Midtown Atlanta

Abby Cox — Fri, 09 Oct 2026 13:38:54 +0000

ATLANTA — The Duracell Co. has relocated its Global Headquarters for Research and Development to Science Square Labs, a 368,213-square-foot laboratory and office tower in Midtown Atlanta. Duracell’s relocation from Bethel, Conn., stems from a multi-year initiative first announced by Georgia officials in February 2025. The project represents a $56 million investment and is projected to generate 100 new jobs in the state. The facility is officially open and operational following a ribbon-cutting ceremony attended by Mayor Andre Dickens. The Atlanta center serves as Duracell’s global innovation hub, where scientists and engineers work across materials science, cell design, laboratory prototyping and device characterization to advance battery performance, quality and safety. Phase I of Science Square, which is anchored by the 13-story Science Square Labs, was delivered in 2025. At full build-out, the district’s master plan allows for approximately 1.8 million square feet of lab and office space, 500 residences and 25,000 square feet of retail space. Additional tenants at Science Square Labs include Georgia Tech and Emory biomedical engineering faculty labs, a Shriners Children’s research institute and utility infrastructure services company Osmose. Science Square Labs is developed and owned by the Trammell Crow Company (TCC) in a joint venture with Georgia…

The post Duracell Opens Regional Office at Science Square Labs in Midtown Atlanta appeared first on REBusinessOnline.

Berkeley Garbe Underway on 150,000 SF Life Sciences Project in Billerica, Massachusetts

Taylor Williams — Fri, 25 Sep 2026 14:32:17 +0000

BILLERICA, MASS. —Berkeley Garbe, a Boston-based developer that is a joint venture between Berkeley Investments and German real estate company GARBE, is underway on construction of a 150,000-square-foot life sciences project in Billerica, located northwest of the state capital. The site spans 23 acres at 161 Concord Road, and the new building will support manufacturers in industries such as aerospace, robotics, medical devices, semiconductors, computer hardware and battery technologies. Building features will include a clear height of 28 feet and 264 car parking spaces. Avison Young is the leasing agent for the project. Construction began in June and is expected to be complete next spring, and Berkeley Garbe has since received an additional $35.4 million in financing for the project from MetLife Investment Management. Andrew Kaeyer led a capital markets team at Hunneman that arranged the debt of behalf of the developer.

The post Berkeley Garbe Underway on 150,000 SF Life Sciences Project in Billerica, Massachusetts appeared first on REBusinessOnline.

AdvanCell Signs 128,000 SF Life Sciences Lease in Andover, Massachusetts

Taylor Williams — Thu, 17 Sep 2026 14:33:00 +0000

ANDOVER, MASS. — AdvanCell has signed a 128,000-square-foot life sciences lease in the northern Boston suburb of Andover. The clinical-stage radiopharmaceutical company will occupy the entirety of the building at 1 Corporate Drive, which is located within Innovation Park, a 340,000-square-foot development. The deal brings Phase II of Innovation Park, which is owned by life sciences REIT IQHQ, to full occupancy. Information on third-party brokers who were involved in the lease negotiations was not disclosed.

The post AdvanCell Signs 128,000 SF Life Sciences Lease in Andover, Massachusetts appeared first on REBusinessOnline.

Genentech Tops Out $2B Manufacturing Facility in Holly Springs, North Carolina

Kristin Harlow — Wed, 19 Aug 2026 12:00:00 +0000

HOLLY SPRINGS, N.C. — Genentech, a biotechnology company and member of the Roche Group, has topped out its new $2 billion manufacturing facility in Holly Springs, about 20 miles southwest of Raleigh. The construction milestone marks the completion of the building’s structural framework. The project is Genentech’s first East Coast manufacturing facility. The development was initially announced in May 2025, followed by the groundbreaking in August 2025 and an expansion announcement in January 2026. Once operational, the facility will produce next-generation treatments for metabolic conditions such as obesity. Its operations will incorporate advanced biomanufacturing, automation, robotics and the latest digital manufacturing technologies. The investment in technology includes an advanced digital twin — an artificial intelligence-powered virtual model of the manufacturing facility designed to simulate operations and test scenarios before real-world implementation. The facility is expected to support more than 2,000 jobs, including 500 manufacturing roles and 1,500 construction jobs. Genentech is also partnering with local academic institutions to prepare future members of the workforce for manufacturing careers. The project is part of Switzerland-based Roche and Genentech’s broader $50 billion commitment to research and development (R&D) and manufacturing infrastructure in the United States. Roche and Genentech’s current U.S. footprint includes 13…

The post Genentech Tops Out $2B Manufacturing Facility in Holly Springs, North Carolina appeared first on REBusinessOnline.

Breakthrough Properties Buys Biomanufacturing Facility Near Seattle for $78M

Amy Works — Mon, 17 Aug 2026 13:26:53 +0000

EVERETT, WASH. — Breakthrough, a joint venture of Tishman Speyer and Bellco Capital, has acquired a biomanufacturing facility in Everett, a suburb of Seattle, for $78 million. In tandem with the acquisition, Breakthrough secured a separate 21-year lease for the entire campus with a global biopharmarceutical company to create a U.S. manufacturing facility. The 270,000-square-foot facility can support a range of uses, including drug manufacturing, quality-control lab operations and, warehouse/distribution functions. The property also offers administrative office spaces and an onsite café. The site, located at 215 Shuksan Way, was originally leased to a biotechnology company that invested approximately $350 million to build out a biomanufacturing facility but never moved in after being acquired in 2023. The transaction marks Breakthrough’s first investment in the Puget Sound region. The name of the seller was not released.

The post Breakthrough Properties Buys Biomanufacturing Facility Near Seattle for $78M appeared first on REBusinessOnline.

French Biotech Company to Open U.S. Lab Space in Topeka, Kansas

Kristin Harlow — Tue, 11 Aug 2026 13:03:34 +0000

TOPEKA, KAN. — Spore.Bio, a biotechnology company headquartered in France with an existing U.S. presence in New York, has unveiled plans to become the first laboratory tenant at Link Innovation Labs in Topeka. Located in the heart of Topeka’s Innovation District, Link Innovation Labs provides flexible private lab suites, shared equipment, collaboration areas and resources designed to help companies accelerate research, commercialization and growth. Organizations located within Link Innovation Labs include Plug and Play Topeka, the Washburn Small Business Development Center and Sparrow Coffee at Link.

The post French Biotech Company to Open U.S. Lab Space in Topeka, Kansas appeared first on REBusinessOnline.

Bristol Myers Squibb to Open $2.3B Pharmaceutical Manufacturing Campus in Houston

John Nelson — Tue, 11 Aug 2026 11:53:00 +0000

HOUSTON — Bristol Myers Squibb (NYSE: BMY), a global pharmaceutical company best known for manufacturing treatments and medications such as Opdivo and Eliquis, will open a $2.3 billion manufacturing campus in Houston. The Princeton, N.J.-based firm chose a site within McCord Development’s 4,300-acre Generation Park for the approximately 600,000-square-foot project. “This investment reflects our confidence in America’s continued leadership in biopharmaceutical innovation,” says Christopher Boerner, board chair and CEO of Bristol Myers Squibb. “As part of our $40 billion commitment to the United States, we’re building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure and partnership needed to help bring that vision to life.” Situated in northeast Houston, Bristol Myers Squibb’s new campus will be designed to be both modular and multi-modal, allowing the company to reconfigure manufacturing capacity for multiple types of medicines — including small molecules, biologics and antibody-drug conjugates — as needs arise. The new campus is estimated to create nearly 500 skilled jobs in the Houston area for roles including operations technicians, production specialists, maintenance and engineering professionals, quality control/assurance experts and administration. Bristol Myers Squibb also anticipates…

The post Bristol Myers Squibb to Open $2.3B Pharmaceutical Manufacturing Campus in Houston appeared first on REBusinessOnline.

Osmo Opens 60,000 SF Headquarters Facility in Elizabeth, New Jersey

Taylor Williams — Wed, 05 Aug 2026 13:15:07 +0000

ELIZABETH, N.J. — Osmo, which uses machine learning to digitize scent and promote olfactory science, has opened a 60,000-square-foot headquarters facility in the Northern New Jersey community of Elizabeth. Designed by KSS Architects, the facility includes office, lab and manufacturing space, as well as a breakout room, café and shared spaces to foster cross-disciplinary collaboration. A partnership between Bridge Industrial and Elberon Development Group owns the building, the address of which was not disclosed.

The post Osmo Opens 60,000 SF Headquarters Facility in Elizabeth, New Jersey appeared first on REBusinessOnline.

Cincinnati: A Market Defined by Industrial Strength, Life Sciences Growth

Kristin Harlow — Thu, 30 Jul 2026 12:30:00 +0000

By Kimm Lauterbach, REDI Cincinnati Shaped by its strong German heritage, brewing tradition and historic role as the nation’s pork-processing capital, earning the nickname “Porkopolis,” the Cincinnati region has long been defined by industry, entrepreneurship and innovation. That legacy of reinvention has transformed Cincinnati into one of the Midwest’s most resilient and strategically positioned economic development markets. Anchored by a diverse economy, a central location within a one-day drive of nearly 60 percent of the U.S. population and a growing concentration of advanced industries, the region is experiencing sustained investment across industrial and life sciences. Unlike many peer markets that are dependent on a single industry, Cincinnati benefits from a balanced economic base led by advanced manufacturing, life sciences, aerospace and aviation, food and beverage and logistics. For the first quarter of 2026, REDI Cincinnati has welcomed the highest number of site visits since our inception. Industrial powerhouse Industrial real estate remains the strongest-performing commercial sector in the Cincinnati market. Cincinnati’s industrial vacancy rate stood at approximately 5.4 percent during the first quarter of 2026, according to Cushman & Wakefield, reflecting a healthy and balanced market despite significant inventory growth over the last several years. Positive absorption has continued,…

The post Cincinnati: A Market Defined by Industrial Strength, Life Sciences Growth appeared first on REBusinessOnline.

Breakthrough Properties, Tishman Speyer Provide $90M Loan for 538,000 SF Life Sciences Campus in San Diego

Amy Works — Fri, 24 Jul 2026 13:25:28 +0000

SAN DIEGO — Breakthrough Properties and Tishman Speyer have provided a $90 million mezzanine bridge loan for Aperture Del Mar, a Class A life sciences campus in San Diego. The borrower, Gemdale USA, will use the proceeds to refinance an existing loan. Totaling 538,000 square feet, the four-building lab and office campus is fully occupied by Neurocrine Biosciences, a biopharmaceutical company. The campus features a standalone fitness center with a yoga studio and juice bar, outdoor event lawn, private patios, courtyard and a 1,500-stall parking garage. Aperture Del Mar serves as Neurocrine’s mission-critical global headquarters as part of a lease that funds through 2036. Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, develops and owns life sciences real estate in San Diego and other markets around the world. Tishman Speyer directly participated in the financing through its recently established debt platform.

The post Breakthrough Properties, Tishman Speyer Provide $90M Loan for 538,000 SF Life Sciences Campus in San Diego appeared first on REBusinessOnline.

Living Proof Signs 14,085 SF Office, Life Sciences Lease in Boston’s Seaport District

Taylor Williams — Wed, 24 Jun 2026 13:27:15 +0000

BOSTON — Living Proof has signed a 14,085-square-foot lease in Boston’s Seaport District. The provider of hair care products will relocate its operations from the Innovation & Design Building to the entire fifth floor of the office and life sciences building at 12 Farnsworth St. Tim Lahey of CBRE represented the tenant in the lease negotiations. Eric Smith and Lauren Drakeley, also with CBRE, represented the landlord, Phase 3 Real Estate Partners.

The post Living Proof Signs 14,085 SF Office, Life Sciences Lease in Boston’s Seaport District appeared first on REBusinessOnline.

Federal Government Agencies Break Ground on $228M Food Lab Near Denver

Taylor Williams — Mon, 22 Jun 2026 11:57:00 +0000

LAKEWOOD, COLO. — The U.S. General Services Administration (GSA), U.S. Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) have broken ground on a $228 million food lab in Lakewood, a southwestern suburb of Denver. According to Colorado Politics, the site is located within Denver Federal Center, a complex that spans 4 million square feet of space across 90 buildings. The complex houses operations of 28 federal agencies representing some 6,200 employees, according to the local publication. The new food lab will include 16,500 square feet of new lab space for microbiology functions and 14,000 square feet for chemistry initiatives. The facility will be used to support the FDA’s management of foodborne illness outbreaks and ensure product safety for food, drugs and cosmetics. Completion is slated for 2029. The exterior design of the facility will feature a neoclassical style that reflects President Donald Trump’s executive order to “making federal architecture beautiful again.” The interior of the facility will include controlled access and a sustained directional airflow system. Additionally, the property will be the FDA’s only Biosafety Level 3 facility west of the Mississippi River. “Laboratories are vital to the FDA’s mission to ensure the safety of…

The post Federal Government Agencies Break Ground on $228M Food Lab Near Denver appeared first on REBusinessOnline.

Newmark Brokers $68M Sale of Life Sciences, Biomanufacturing Facility in Providence

Taylor Williams — Thu, 18 Jun 2026 15:04:11 +0000

PROVIDENCE, R.I. — Newmark has brokered the $68 million sale of a life sciences and biomanufacturing facility in Providence. The 122,507-square-foot facility at 100 Technology Way was originally developed in 1993 and was fully leased at the time of sale to Organogenesis (NASDAQ: ORGO), a provider of regenerative medicine solutions. New York City-based investment firm Lightstone acquired the property from local owner-operator The Davis Cos. Robert Griffin, Jim Tribble, Samantha Hallowell, Tyler McGrail and William Sleeper of Newmark brokered the deal. The property is currently in the midst of a $100 million capital improvement program.

The post Newmark Brokers $68M Sale of Life Sciences, Biomanufacturing Facility in Providence appeared first on REBusinessOnline.

Rover Diagnostics Signs 15,763 SF Life Sciences Lease in Queens

Taylor Williams — Thu, 18 Jun 2026 14:45:10 +0000

NEW YORK CITY — Rover Diagnostics has signed a 15,763-square-foot life sciences lease in Queens. The space is located on the ground floor of Innolabs, a 266,800-square-foot development in the borough’s Long Island City area. Tom Burrus of JLL represented Rover Diagnostics in the lease negotiations. Bill Harvey and John Cahill, also with JLL, represented the landlord, a partnership between King Street Properties and GFP Real Estate.

The post Rover Diagnostics Signs 15,763 SF Life Sciences Lease in Queens appeared first on REBusinessOnline.

Telecommunications Firm Signs 42,000 SF Lease at Flex Building in Richardson, Texas

Taylor Williams — Wed, 17 Jun 2026 14:42:39 +0000

RICHARDSON, TEXAS — ANDREW, a hardware manufacturer for the telecommunications industry, has signed a 42,000-square-foot lease in the northeastern Dallas suburb of Richardson. The company is relocating from the nearby building at 2601 Telecom Parkway to the flex building at 2920 Telecom Parkway. In addition to office, the company’s new space supports lab, manufacturing and engineering uses. As part of the relocation, ANDREW plans to invest more than $2 million to support tenant improvements and the addition of new furniture, fixtures and equipment at its new Richardson facility.

The post Telecommunications Firm Signs 42,000 SF Lease at Flex Building in Richardson, Texas appeared first on REBusinessOnline.

Biocytogen Signs 35,000 SF Life Sciences Lease Expansion in Waltham, Massachusetts

Taylor Williams — Wed, 17 Jun 2026 13:36:05 +0000

WALTHAM, MASS. — Biocytogen, which provides animal and cell model generation for preclinical research, has signed a 35,000-square-foot life sciences lease in Waltham, a western suburb of Boston. Biocytogen now occupies about 70,000 square feet at the 143,533-square-foot building at 300 Third Ave. Tim Allen of Colliers represented the tenant in the lease negotiations. Tim Latham, Christopher Scott and Chris Devaux represented the landlord, Dallas-based Lincoln Property Co., on an internal basis.

The post Biocytogen Signs 35,000 SF Life Sciences Lease Expansion in Waltham, Massachusetts appeared first on REBusinessOnline.

Joint Venture Refinances 615,305 SF Office, Life Sciences Campus in Bedford, Massachusetts

Taylor Williams — Thu, 04 Jun 2026 14:45:59 +0000

BEDFORD, MASS. — A joint venture between Anchor Line Partners and Alloy Properties has refinanced The Core at Crosby, a 615,305-square-foot office and life sciences campus in Bedford, a northwestern suburb of Boston. Berlin Hyp, the commercial real estate finance arm of LBBW, provided the debt for the nine-building campus, which is anchored by software provider AspenTech. Robert Griffin, David Douvadjian Sr., David Douvadjian Jr., Timothy O’Donnell, Edward Maher and Matthew Pullen of Newmark arranged the debt on behalf of the joint venture.

The post Joint Venture Refinances 615,305 SF Office, Life Sciences Campus in Bedford, Massachusetts appeared first on REBusinessOnline.